Forma Therapeutics formatherapeutics.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Forma Therapeutics is an oncology focused target discovery, screening, structural biology and small molecule developer. FORMA Therapeutics' scientists are passionate about discovering and developing medicines that will make a difference in oncology and other genetically driven therapeutic areas. The company's drug discovery engine drives screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis and protein-protein int...Show all

Forma Therapeutics is an oncology focused target discovery, screening, structural biology and small molecule developer. FORMA Therapeutics' scientists are passionate about discovering and developing medicines that will make a difference in oncology a...Show all

Company (Alive / Active)

Phone: 617-679-1970

Fax:

500 Arsenal Street
Suite 100
Watertown, 02472
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Forma Therapeutics $29.5M Apr 1, 2014
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Forma Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors

Competitors

Company Status Description Investors

Cognition Therapeutics

Pittsburgh, Pennsylvania, United States
Alive / ActiveCognition Therapeutics is focused on the discovery and development of small molecule therapeutics targeting toxic proteins that cause the cognitive decline associated with Alzheimer's disease and other degenerative diseases of the human brain. Toxic proteins play a crucial role in a large number of human diseases, and there are currently no therapeutics available to prevent toxic protein accumulation or block their destructive effects. Cognition is founded on the combination of biological expert...Show allLogin to see details

Five Prime Therapeutics

South San Francisco, California, United States
IPO / Went publicFive Prime Therapeutics is a clinical-stage biotechnology company with a pipeline of antibodies and ligand traps for cancer, autoimmunity and respiratory diseases. FivePrime has differentiated discovery capabilities built on its library of secreted and extracellular human proteins, which it leverages in cell-based assays, in vivo models and receptor-ligand matching screens to identify medically relevant new targets and therapeutic proteins. FivePrime has entered into a collaboration agreement to...Show allLogin to see details
See all 15 competitors